Thursday, March 14, 2013 9:16:00 PM
"chimeric silkworm/spider silk proteins"... that produce "composite silk fibers"...
It says exactly what I did... that they have fibers formed from mixing silkworm and spider proteins... that produce a mixture... or a composite... only they're saying it with a positive spin that avoids addressing known problems.
The mixture is "stronger than the silkworm silk" as we know, and as you would expect from adding the spider silk proteins to the mix.
That doesn't begin to address the issue with a resulting lack of uniformity and variation in strength within a fiber... when uniformity and consistent strength are important factors you consider in the utility of any fiber, along with consistent repeat-ability in the production of fibers with some demonstrated uniformity between them.
There's nothing wrong with KBLB being happy with progress that has them "doing things that have never been done before"... which doesn't mean that accomplishing what they have... pushes them past any threshold that will matter to potential customers any time soon. Being pleased with reaching a milestone... isn't justification for misrepresenting the likely market impact of having it be reached.
It's the weakest link that matters... so having a tougher chain than the other guy... when the tougher links if spider protein are still being linked together with rubber bands... doesn't mean customers will focus on the toughness of the best links in the chain... rather than the impact resulting from having rubber bands connecting them as the limiting factor in application.
It will be the variation in the fibers that matters...
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM